The loss of NKX3.1 expression in testicular - And prostate - Cancers is not caused by promoter hypermethylation

Molecular Cancer

Volumn 4, Issue , 2005, Pages

  Lind, Guro E ^a   Skotheim, Rolf I ^a   Fraga, Mario F ^b   Abeler, Vera M ^a   Henrique, Rui ^c   Saatcioglu, Fahri ^d   Esteller, Manel ^b   Teixeira, Manuel R ^c   Lothe, Ragnhild A ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; HISTONE; HOMEODOMAIN PROTEIN; PROTEIN NKX3.1; UNCLASSIFIED DRUG; NKX3 1 PROTEIN, HUMAN; NKX3-1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

CHROMATIN STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; GENE SEQUENCE; GERM CELL TUMOR; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN MODIFICATION; REGULATORY MECHANISM; REVIEW; SEQUENCE ANALYSIS; TESTIS CANCER; TUMOR CELL LINE; ADENOCARCINOMA; ARTICLE; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PROSTATE TUMOR; TESTIS TUMOR; TUMOR CELL CULTURE;

ADENOCARCINOMA; BASE SEQUENCE; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GERMINOMA; HOMEODOMAIN PROTEINS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; TESTICULAR NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 13644259352     PISSN: 14764598     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-4598-4-8     Document Type: Review

References (28)

1. Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi OP, Gelmann EP: Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res 2000, 60:6111-6115.
2. He WW, Sciavolino PJ, Wing J, Augustus M, Hudson P, Meissner PS, Curtis RT, Shell BK, Bostwick DG, Tindall DJ, Gelmann EP, Abate-Shen C, Carter KC: A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics 1997, 43:69-77.
3. Prescott JL, Blok L, Tindall DJ: Isolation and androgen regulation of the human homeobox cDNA, NKX3.1. Prostate 1998, 35:71-80.
4. Gelmann EP, Bowen C, Bubendorf L: Expression of NKX3.1 in normal and malignant tissues. Prostate 2003, 55:111-117.
5. Skotheim RI, Korkmaz KS, Klokk TI, Abeler VM, Korkmaz CG, Nesland JM, Fosså SD, Lothe RA, Saatcioglu F: NKX3.1 expression is lost in testicular germ cell tumors. Am J Pathol 2003, 163: 149-2154.
6. Voeller HJ, Augustus M, Madike V, Bova GS, Carter KC, Gelmann EP: Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Cancer Res 1997, 57:4455-4459.
7. Swalwell JI, Vocke CD, Yang Y, Walker JR, Grouse L, Myers SH, Gillespie JW, Bostwick DG, Duray PH, Linehan WM, Emmert-Buck MR: Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer. Genes Chromosomes Cancer 2002, 33: 01-205.
8. Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Liotta LA, Emmert-Buck MR, Linehan WM: Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res 1996, 56:2411-2416.
9. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, Linehan WM: Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 1995, 55:2959-2962.
10. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR, Abate-Shen C, Shen MM: Roles for Nkx3.1 in prostate development and cancer. Genes Dev 1999, 13:966-977.
11. Abdulkadir SA, Magee JA, Peters TJ, Kaleem Z, Naughton CK, Humphrey PA, Milbrandt J: Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Mol Cell Biol 2002, 22:1495-1503.
12. Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, Desai N, Wang Y, Hayward SW, Cunha GR, Cardiff RD, Shen MM, Abate-Shen C: Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res 2002, 62:2999-3004.
13. Korkmaz CG, Korkmaz KS, Manola J, Xi Z, Risberg B, Danielsen H, Kung J, Sellers WR, Loda M, Saatcioglu F: Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis. J Urol 2004, 172:1134-1139.
14. Xu LL, Srikantan V, Sesterhenn IA, Augustus M, Dean R, Moul JW, Carter KC, Srivastava S: Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer. J Urol 2000, 163:972-979.
15. Ornstein DK, Cinquanta M, Weiler S, Duray PH, Emmert-Buck MR, Vocke CD, Linehan WM, Ferretti JA: Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium. J Urol 2001, 165:1329-1334.
16. Shen MM, Abate-Shen C: Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev Dyn 2003, 228:767-778.
17. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-428.
18. Esteller M: Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv Exp Med Biol 2003, 532:39-49.
19. Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349:2042-2054.
20. Harrison J, Stirzaker C, Clark SJ: Cytosines adjacent to methylated CpG sites can be partially resistant to conversion in genomic bisulphite sequencing leading to methylation artifacts. Anal Biochem 1998, 264:129-132.
21. Mostofi FK, Sesterhenn IA: World Health Organization International Histological Classification of Tumours: Histological typing of testis tumours. Berlin: Springer-Verlag; 1998.
22. Kraggerud SM, Skotheim RI, Szymanska J, Eknæs M, Fosså SD, Stenwig AE, Peltomaki P, Lothe RA: Genome Profiles of Familiar/Bilateral and Sporadic Testicular Germ Cell Tumors. Genes Chromosomes Cancer 2002, 34:168-174.
23. Gleason DF, Mellinger GT: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974, 111:58-64.
24. Grunau C, Clark SJ, Rosenthal A: Bisulphite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001, 29:E65.
25. Fraga MF, Esteller M: DNA methylation: a profile of methods and applications. Biotechniques 2002, 33:632-649.
26. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996, 93:9821-9826.
27. Clark SJ, Harrison J, Paul CL, Frommer M: High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994, 22: 990-2997.
28. Melki JR, Vincent PC, Clark SJ: Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 1999, 59:3730-3740.